New CAR T Therapy Brings 80% Response Rate for Blood Cancer

A breakthrough immune therapy is transforming multiple myeloma from a disease that always returned into one where patients can reach long-term remission.

More than 36,000 Americans diagnosed this year now have access to treatments once considered impossible.